Cancer Biopsy Global Market Report 2025

Description

A cancer biopsy is a medical procedure in which a small sample of tissue or cells is extracted from a suspicious area of the body to determine the presence of cancer or other conditions. This procedure is essential for diagnosing cancer, as imaging tests such as CT scans or MRIs cannot definitively differentiate between cancerous and non-cancerous cells.

The primary types of cancer biopsies include tissue biopsies, liquid biopsies, and others. Tissue biopsies involve extracting a small tissue sample from the body for microscopic examination. These procedures are used to diagnose various types of cancer, including breast, colorectal, cervical, lung, prostate, skin, blood, kidney, and other cancers. They are employed by different end users, such as hospitals, diagnostic laboratories, and other healthcare facilities.

The cancer biopsy market research report is one of a series of new reports from The Business Research Company that provides cancer biopsy market statistics, including cancer biopsy industry global market size, regional shares, competitors with a cancer biopsy market share, detailed cancer biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer biopsy industry. This cancer biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer biopsy market size has grown rapidly in recent years. It will grow from $25.08 $ billion in 2024 to $28.52 $ billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing awareness of breast cancer liquid biopsy procedures, rising awareness of inherited oncology disorders and genetic testing, increasing adoption of liquid biopsies, increasing demand of for minimally invasive biopsy treatments, increasing demand for tissue biopsies.

The cancer biopsy market size is expected to see rapid growth in the next few years. It will grow to $47.2 $ billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to an increase in the number of patients, the growing elderly population, the growing number of patients suspected of having breast cancer, the rise in cancer cases, an increase in the diagnosis and biopsies testing, increase in the number of patients. Major trends in the forecast period include technological advancements, artificial intelligence and machine learning, integration of multi-omics, product innovations, and point-of-care biopsy devices.

The increasing incidence of cancer is expected to drive growth in the cancer biopsy market. Cancer, characterized by abnormal cell growth and spread, is becoming more prevalent due to factors such as lifestyle changes, urbanization, environmental pollution, tobacco and alcohol consumption, and disparities in healthcare access and awareness. Cancer biopsies are crucial for diagnosing and assessing cancer type, stage, and progression by extracting and analyzing tissue or cells from suspicious areas. For instance, the National Center for Biotechnology Information reported in January 2023 that the United States had 1,958,310 new cancer cases and 609,820 cancer-related deaths. Additionally, a May 2021 report from the National Library of Medicine forecasted a global cancer burden of 28.4 million cases by 2040, representing a 47% increase from 2020, along with a corresponding rise in mortality rates. This growing prevalence is a significant factor driving the demand for cancer biopsies.

Key players in the cancer biopsy market are advancing liquid biopsy technologies to enable non-invasive, early detection and monitoring of cancer, thereby improving patient outcomes and supporting more personalized treatment approaches. Liquid biopsy is an advanced diagnostic method that analyzes genetic material in blood samples, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. In May 2023, Labcorp, a US-based leader in cancer biopsy solutions, launched Labcorp Plasma Focus, a plasma-based liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) from tumor cells in the bloodstream to generate a genomic profile of the patient's tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

In June 2023, Quest Diagnostics, a US-based provider of diagnostic information services, acquired Haystack Oncology for up to $450 million. This acquisition aims to enhance Quest Diagnostics' expertise in cancer diagnostics, particularly in the detection of minimal residual disease (MRD). Haystack Oncology is a US-based company that specializes in liquid biopsy technology for cancer detection.

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

North America was the largest region in the cancer biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer biopsy market consists of sales of biopsy needles, biopsy guns, and biopsy punches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Tissue Biopsies; Liquid Biopsies; Other Types
2) By Application: Breast Cancer; Colorectal Cancer; Cervical Cancers; Lung Cancers; Prostate Cancers; Skin Cancers; Blood Cancers; Kidney Cancers; Other Applications
3) By End User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Tissue Biopsies: Core Needle Biopsies; Fine Needle Aspiration (FNA) Biopsies; Incisional Biopsies; Excisional Biopsies
2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis; Circulating Tumor DNA (ctDNA) Testing; Plasma Biomarker Testing
3) By Other Types: Bone Biopsies; Endoscopic Biopsies; Brush Biopsies; Skin Biopsies
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Roche Diagnostics GmbH; Hologic Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31693

1. Executive Summary

2. Cancer Biopsy Market Characteristics

3. Cancer Biopsy Market Trends And Strategies

4. Cancer Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Biopsy Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Biopsy Market Growth Rate Analysis
5.4. Global Cancer Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Biopsy Total Addressable Market (TAM)

6. Cancer Biopsy Market Segmentation

6.1. Global Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tissue Biopsies
Liquid Biopsies
Other Types
6.2. Global Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Other Applications
6.3. Global Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Other End Users
6.4. Global Cancer Biopsy Market, Sub-Segmentation Of Tissue Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Core Needle Biopsies
Fine Needle Aspiration (FNA) Biopsies
Incisional Biopsies
Excisional Biopsies
6.5. Global Cancer Biopsy Market, Sub-Segmentation Of Liquid Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Circulating Tumor Cell (CTC) Analysis
Circulating Tumor DNA (ctDNA) Testing
Plasma Biomarker Testing
6.6. Global Cancer Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Biopsies
Endoscopic Biopsies
Brush Biopsies
Skin Biopsies

7. Cancer Biopsy Market Regional And Country Analysis

7.1. Global Cancer Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Biopsy Market

8.1. Asia-Pacific Cancer Biopsy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Biopsy Market

9.1. China Cancer Biopsy Market Overview
9.2. China Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Biopsy Market

10.1. India Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Biopsy Market

11.1. Japan Cancer Biopsy Market Overview
11.2. Japan Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Biopsy Market

12.1. Australia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Biopsy Market

13.1. Indonesia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Biopsy Market

14.1. South Korea Cancer Biopsy Market Overview
14.2. South Korea Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Biopsy Market

15.1. Western Europe Cancer Biopsy Market Overview
15.2. Western Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Biopsy Market

16.1. UK Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Biopsy Market

17.1. Germany Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Biopsy Market

18.1. France Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Biopsy Market

19.1. Italy Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Biopsy Market

20.1. Spain Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Biopsy Market

21.1. Eastern Europe Cancer Biopsy Market Overview
21.2. Eastern Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Biopsy Market

22.1. Russia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Biopsy Market

23.1. North America Cancer Biopsy Market Overview
23.2. North America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Biopsy Market

24.1. USA Cancer Biopsy Market Overview
24.2. USA Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Biopsy Market

25.1. Canada Cancer Biopsy Market Overview
25.2. Canada Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Biopsy Market

26.1. South America Cancer Biopsy Market Overview
26.2. South America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Biopsy Market

27.1. Brazil Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Biopsy Market

28.1. Middle East Cancer Biopsy Market Overview
28.2. Middle East Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Biopsy Market

29.1. Africa Cancer Biopsy Market Overview
29.2. Africa Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Biopsy Market Competitive Landscape And Company Profiles

30.1. Cancer Biopsy Market Competitive Landscape
30.2. Cancer Biopsy Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Biopsy Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Bio-Rad Laboratories Inc.
31.3. QIAGEN N.V.
31.4. Exact Sciences Corporation
31.5. Myriad Genetics Inc.
31.6. Guardant Health Inc.
31.7. Veracyte Inc.
31.8. GRAIL Inc.
31.9. Freenome Holdings Inc.
31.10. Biodesix Inc.
31.11. Chronix Biomedical Inc.
31.12. Biocept Inc.
31.13. Personal Genome Diagnostics Inc.
31.14. Agena Bioscience Inc.
31.15. Oncimmune Holdings plc

32. Global Cancer Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Biopsy Market

34. Recent Developments In The Cancer Biopsy Market

35. Cancer Biopsy Market High Potential Countries, Segments and Strategies

35.1 Cancer Biopsy Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Biopsy Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Biopsy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer